Lung Nodule Study
ORACLE Clinical Study: An Observational Registry Study to Evaluate the Performance of the Nodify XL2™ Test
ORACLE is a multicenter, prospective observational registry study to evaluate the impact of the Nodify XL2 integrated classifier when used in the clinical management of recently identified lung nodules assessed to have a low to moderate risk of cancer.
The primary objective of the study is to demonstrate a significant reduction in the proportion of invasive procedures (biopsies or surgery) performed on patients with benign lung nodules as compared to current standard of care in lung nodule management.